201 related articles for article (PubMed ID: 15868394)
1. Evidence-based pharmacological treatment of neuropathic pain syndromes.
Beniczky S; Tajti J; Tímea Varga E; Vécsei L
J Neural Transm (Vienna); 2005 Jun; 112(6):735-49. PubMed ID: 15868394
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.
Vadalouca A; Raptis E; Moka E; Zis P; Sykioti P; Siafaka I
Pain Pract; 2012 Mar; 12(3):219-51. PubMed ID: 21797961
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain and pharmacological treatment.
Jongen JL; Hans G; Benzon HT; Huygen F; Hartrick CT
Pain Pract; 2014 Mar; 14(3):283-95. PubMed ID: 23750502
[TBL] [Abstract][Full Text] [Related]
4. Painful peripheral neuropathy and its nonsurgical treatment.
Wolfe GI; Trivedi JR
Muscle Nerve; 2004 Jul; 30(1):3-19. PubMed ID: 15221874
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.
Ney JP; Devine EB; Watanabe JH; Sullivan SD
Pain Med; 2013 May; 14(5):706-19. PubMed ID: 23691937
[TBL] [Abstract][Full Text] [Related]
6. The Pharmacological Therapy of Chronic Neuropathic Pain.
Binder A; Baron R
Dtsch Arztebl Int; 2016 Sep; 113(37):616-625. PubMed ID: 27697147
[TBL] [Abstract][Full Text] [Related]
7. Treatment of painful peripheral neuropathy.
Trivedi JR; Silvestri NJ; Wolfe GI
Neurol Clin; 2013 May; 31(2):377-403. PubMed ID: 23642715
[TBL] [Abstract][Full Text] [Related]
8. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain in children: Special considerations.
Walco GA; Dworkin RH; Krane EJ; LeBel AA; Treede RD
Mayo Clin Proc; 2010 Mar; 85(3 Suppl):S33-41. PubMed ID: 20194147
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.
Vadalouca A; Siafaka I; Argyra E; Vrachnou E; Moka E
Ann N Y Acad Sci; 2006 Nov; 1088():164-86. PubMed ID: 17192564
[TBL] [Abstract][Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for neuropathic pain.
Jackson KC
Pain Pract; 2006 Mar; 6(1):27-33. PubMed ID: 17309706
[TBL] [Abstract][Full Text] [Related]
13. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
Horga de la Parte JF; Horga A
Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
Hall GC; Carroll D; Parry D; McQuay HJ
Pain; 2006 May; 122(1-2):156-62. PubMed ID: 16545908
[TBL] [Abstract][Full Text] [Related]
16. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine in the treatment of pain syndromes and neuropathic pain.
Titlic M; Jukic I; Tonkic A; Josipovic-Jelic Z; Boschi V; Mihalj M; Punda A
Bratisl Lek Listy; 2008; 109(9):421-4. PubMed ID: 19040151
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
Papanas N; Ziegler D
Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
[TBL] [Abstract][Full Text] [Related]
19. Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
Edelsberg J; Oster G
Eur J Pain; 2009 Jan; 13(1):11-6. PubMed ID: 18456524
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
